Clinical Trial Update: The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the safety and preliminary activity of the combination of lapatinib and sorafenib in patients with advanced refractory solid tumors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Lapatinib (Lapatinib)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED